Journal of Experimental & Clinical Cancer Research 2008, 27:87 http://www.jeccr.com/content/27/1/87 18. Hu TH, Wang CC, Huang CC: Down-regulation of tumor sup- pressor gene PTEN, overexpression of p53, plus high prolif- erating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. Oncol Rep 2007, 18(6):1417-1426. 19. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L: PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441(7092):518-522. 2006 May 25; 20. Nissim H, Nahum S: Upstream and downstream of mTOR. Genes & Delvelopment 2004, 18:1926-1945. 21. Cheung AM, Mak TW: PTEN in the haematopoietic system and its therapeutic indications. Trends Mol Med 2006, 12(11):503-505. 22. Récher C, Beyne-Rauzy O, Demur C, Chicanne G, Dos Santos C, Mas VM, Benzaquen D, Laurent G, Huguet F, Payrastre B: Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 2005, 105(6):2527-2534. Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 9 of 9 (page number not for citation purposes)